Home/Filings/4/0001214659-25-004643
4//SEC Filing

Katzoff David J 4

Accession 0001214659-25-004643

CIK 0001677077other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 7:30 AM ET

Size

4.6 KB

Accession

0001214659-25-004643

Insider Transaction Report

Form 4
Period: 2025-03-21
Katzoff David J
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-03-21$1.01/sh+5,000$5,0485,540 total

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1
  • filerCIK 0001864317

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 7:30 AM ET
Size
4.6 KB